Tag: nephrology drugs market overview

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How Much Growth is Expected for the Nephrology Drugs Market from 2024 to 2033?

There has been a substantial expansion in the market size for nephrology drugs in the last few years. The value will escalate from $16.18 billion in 2023 to $17.08 billion in 2024, with a compound annual growth rate (CAGR) of 5.6%. The historic period’s growth is attributable to increased cases of chronic kidney diseases (ckd), advancements in the development of drugs, improved awareness, and diagnosis, governmental endeavors, and healthcare regulations, as well as a rising occurrence of diabetes.

The market for nephrology drugs is projected to experience significant expansion in the coming years, growing to a notable $21.53 billion in 2028 with a compound annual growth rate (CAGR) of 6.0%. The projected growth in the forecast period is set to be driven by the rise of new therapies and drug innovations, precision medicine and personalized treatments, increased spending in healthcare, telehealth and remote patient supervision, as well as global health initiatives. The forecasted period will witness major trends such as collaborations and partnerships, advancements in dialysis technology, improved treatment modalities, an increased focus on early diagnosis and intervention, along with an integration of technology in nephrology management.

Claim Your Free Sample of the Global Nephrology Drugs Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10076&type=smp

What Factors Are Encouraging Growth in the nephrology drugs Market?

The escalating incidence of chronic kidney disease (CKD) is predicted to fuel the nephrology drugs market’s expansion. CKD is characterized by kidney damage that impairs their functioning, preventing them from properly filtering blood. This leads to waste products building up in the body over an extended period. Nephrology drugs play a crucial role in treating CKD by improving kidney function and decelerating the disease’s progression, safeguarding the body from further damage, thereby bolstering the nephrology drugs market. For instance, data released by the US-based health watchdog Centers for Disease Control and Prevention (CDC) in July 2022 revealed that upwards of 37 million people were diagnosed with CKD in the US, predominantly those 65 years or older (38 percent). In addition, the Kidney Foundation of Canada, a non-profit organization in Canada, states that 4 million Canadians are afflicted with kidney ailments, with diabetic patients, forming 35 percent, leading in kidney failure diagnoses. These increasingly common cases are anticipated to drive the nephrology drug market’s growth.

Which Segments Play a Vital Role in the Nephrology Drugs Market?

1) By Drugs: Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

What Trends Are Driving Change in the Nephrology Drugs Market?

The trend of product innovation is picking up steam in the nephrology drug market. To secure their place in the market, leading companies are introducing new drugs and products. For example, Zydus Lifesciences Limited., a pharmaceutical company based in India, released OxemiaTM (desidustat) for the treatment of chronic kidney disease (CKD) in March 2022. The drug is an oral, small-molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, providing a suitable solution for anemia. It obtained approval from the Drug Controller General of India based on its Phase III clinical trials, showing positive safety profiles, the downregulation of hepcidin, improved iron mobilization, and a drop in LDL-C in patients with chronic kidney disease. By offering therapy at an affordable cost, and improving the patient’s quality of life, it contributes to reducing the disease burden.

Order Now for Fast Delivery of Your Nephrology Drugs Market Report!

https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

What Regions Are Contributing Significantly to the Growth of the Nephrology Drugs Market?

North America was the largest region in the nephrology drug market in 2023. Europe will be the second-largest growing region in the nephrology drug market in 2023. The regions covered in the nephrology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Nephrology Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the nephrology drugs market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Nephrology Drugs Market Include

1. Nephrology Drugs Market Executive Summary

2. Nephrology Drugs Market Segments

3. Nephrology Drugs Market Size And Template Market Growth Rate

4. Key Nephrology Drugs Market Trends

5. Major Nephrology Drugs Market Drivers

……

25. Key Mergers And Acquisitions In The Nephrology Drugs Market

26. Top Nephrology Drugs Companies

27. Nephrology Drugs Market Opportunities And Strategies

28. Nephrology Drugs Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Monoclonal Antibodies (MAs) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Neurodegenerative Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The nephrology drugs market has witnessed significant growth in recent years, with a steady rise in market size and a promising outlook for the future. The market, valued at $16.18 billion in 2023, is projected to reach $17.08 billion in 2024, representing a compound annual growth rate (CAGR) of 5.6%. This growth is attributed to several key factors, including the increasing prevalence of chronic kidney diseases (CKD), advancements in drug development, rising awareness and diagnosis rates, government initiatives, and healthcare policies.

Strong Growth Trajectory

The market is expected to continue its strong growth in the coming years, reaching $21.53 billion by 2028, with a CAGR of 6.0%. Factors driving this growth include emerging therapies and drug innovations, precision medicine, increasing healthcare expenditure, telehealth and remote patient monitoring, and global health initiatives.

Key Trends Driving Growth

Several key trends are expected to drive growth in the nephrology drugs market. These include collaborations and partnerships, technological advancements in dialysis, advancements in treatment modalities, growing emphasis on early diagnosis and intervention, and technological integration in nephrology management. These trends are expected to shape the future of the market, offering new opportunities for growth and innovation.

View More On The Nephrology Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

Surging Incidence of Diabetes and Hypertension

The high incidence of diabetes and hypertension is expected to fuel the growth of the nephrology drug market in the coming years. Diabetes and hypertension are known to be leading causes of chronic kidney disease, leading to an increased demand for nephrology medicines. For instance, according to the World Health Organization, more than 2.5 million hypertension patients were registered in approximately 15,000 health institutions by April 2022. Similarly, the Centers for Disease Control reported that an estimated 37.3 million people worldwide have diabetes.

Product Innovation Driving Market Dynamics

Product innovation is a key trend in the nephrology drug market, with major companies introducing new products and drugs to sustain their market position. For example, Zydus Lifesciences launched Oxemia (desidustat) for chronic kidney disease in March 2022, providing a convenient therapeutic option for the treatment of anemia. This trend of innovation is expected to continue, offering new treatment options and enhancing patients’ quality of life.

Request A Sample Of The Global Nephrology Drugs Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10076&type=smp

Acquisitions and Mergers to Strengthen Market Presence

Acquisitions and mergers are also shaping the nephrology drugs market, with companies seeking to expand their product portfolios and market presence. In December 2021, CSL Behring AG acquired Vifor Pharma AG for $11.7 billion, expanding its product portfolio in nephrology and dialysis.

Market Segmentation and Regional Outlook

The nephrology drugs market is segmented by drugs, route of administration, distribution channel, and end user. By region, North America was the largest market in 2023, with Europe expected to be the second-largest growing region in 2023.